{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:56:03Z","timestamp":1790088963561,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"15","license":[{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T00:00:00Z","timestamp":1687824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K08AG071794"],"award-info":[{"award-number":["K08AG071794"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s11606-023-08275-4","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T16:02:42Z","timestamp":1687881762000},"page":"3372-3380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-5751","authenticated-orcid":false,"given":"Joshua","family":"Niznik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Col\u00f3n-Emeric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn T.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey J.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Gilliam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,27]]},"reference":[{"issue":"4","key":"8275_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00198-006-0260-5","volume":"18","author":"C Colon-Emeric","year":"2007","unstructured":"Colon-Emeric C, Lyles KW, Levine DA, et al. Prevalence and predictors of osteoporosis treatment in nursing home residents with known osteoporosis or recent fracture. Osteoporosis Int. 2007;18(4):553-559.","journal-title":"Osteoporosis Int."},{"issue":"9","key":"8275_CR2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1007\/s00198-009-0837-x","volume":"20","author":"LM Giangregorio","year":"2009","unstructured":"Giangregorio LM, Jantzi M, Papaioannou A, et al. Osteoporosis management among residents living in long-term care. Osteoporosis Int. 2009;20(9):1471-1478.","journal-title":"Osteoporosis Int."},{"issue":"1","key":"8275_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jamda.2020.11.019","volume":"22","author":"JD Niznik","year":"2021","unstructured":"Niznik JD, Li X, Gilliam MA, et al. Are Nursing Home Residents With Dementia Appropriately Treated for Fracture Prevention? J Am Med Dir Assoc. 2021;22(1):28-35 e23.","journal-title":"J Am Med Dir Assoc."},{"issue":"2","key":"8275_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1532-5415.2008.02119.x","volume":"57","author":"S Parikh","year":"2009","unstructured":"Parikh S, Avorn J, Solomon DH. Pharmacological Management of Osteoporosis in Nursing Home Populations: A Systematic Review. J Am Geriatr Soc. 2009;57(2):327-334.","journal-title":"J Am Geriatr Soc."},{"issue":"4","key":"8275_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamda.2015.01.073","volume":"16","author":"BJ Zarowitz","year":"2015","unstructured":"Zarowitz BJ, Cheng LI, Allen C, et al. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis. J Am Med Dir Assoc. 2015;16(4):341-348.","journal-title":"J Am Med Dir Assoc."},{"key":"8275_CR6","unstructured":"American Medical Directors Association. Osteoporosis and Fracture Prevention in the Long-Term Care Setting Clinical Practice Guideline. 2009. Accessed 10 Nov 2021."},{"issue":"15","key":"8275_CR7","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1503\/cmaj.141331","volume":"187","author":"A Papaioannou","year":"2015","unstructured":"Papaioannou A, Santesso N, Morin SN, et al. Recommendations for preventing fracture in long-term care. CMAJ. 2015;187(15):1135-1144.","journal-title":"CMAJ."},{"key":"8275_CR8","doi-asserted-by":"crossref","unstructured":"Duque G, Iuliano S, Close JCT, et al. Prevention of osteoporotic fractures in residential aged care: Updated consensus recommendations. J Am Med Dir Assoc. 2022;23(5):756-763.","DOI":"10.1016\/j.jamda.2021.12.041"},{"key":"8275_CR9","doi-asserted-by":"crossref","unstructured":"Niznik JD, Gilliam MA, Col\u00f3n-Emeric C, et al. Controversies in osteoporosis treatment of nursing home residents. J Am Med Dir Assoc. 2022;23(12):1928-1934.","DOI":"10.1016\/j.jamda.2022.09.013"},{"issue":"1","key":"8275_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12877-018-0724-4","volume":"18","author":"K Sverdrup","year":"2018","unstructured":"Sverdrup K, Bergh S, Selbaek G, et al. Mobility and cognition at admission to the nursing home - a cross-sectional study. BMC Geriatr. 2018;18(1):30.","journal-title":"BMC Geriatr."},{"issue":"9","key":"8275_CR11","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/gerona\/glw034","volume":"71","author":"SD Berry","year":"2016","unstructured":"Berry SD, Lee Y, Zullo AR, et al. Incidence of Hip Fracture in U.S. Nursing Homes. J Gerontol A Biol Sci Med Sci. 2016;71(9):1230-1234.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"9","key":"8275_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203480","volume":"13","author":"C Vossius","year":"2018","unstructured":"Vossius C, Selbaek G, Saltyte Benth J, et al. Mortality in nursing home residents: A longitudinal study over three years. PLoS One. 2018;13(9):e0203480.","journal-title":"PLoS One."},{"issue":"11","key":"8275_CR13","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jamainternmed.2014.4103","volume":"174","author":"J Tjia","year":"2014","unstructured":"Tjia J, Briesacher BA, Peterson D, et al. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med. 2014;174(11):1763-1771.","journal-title":"JAMA Intern Med."},{"key":"8275_CR14","doi-asserted-by":"crossref","unstructured":"Garber J, Brownlee S. 2019. Medication overload: america\u2019s other drug problem. Brookline: The Lown Institute.","DOI":"10.46241\/LI.WOUK3548"},{"issue":"7","key":"8275_CR15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1532-5415.2008.01741.x","volume":"56","author":"HM Holmes","year":"2008","unstructured":"Holmes HM, Sachs GA, Shega JW, et al. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56(7):1306-1311.","journal-title":"J Am Geriatr Soc."},{"issue":"2","key":"8275_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00198-021-06141-9","volume":"33","author":"JD Niznik","year":"2022","unstructured":"Niznik JD, Aspinall SL, Hanson LC, et al. Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia. Osteoporos Int. 2022;33(2):379-390.","journal-title":"Osteoporos Int."},{"issue":"5","key":"8275_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/MLR.0000000000001294","volume":"58","author":"JR Curtis","year":"2020","unstructured":"Curtis JR, Saag KG, Arora T, et al. Duration of Bisphosphonate Drug Holidays and Associated Fracture Risk. Med Care. 2020;58(5):419-426.","journal-title":"Med Care."},{"issue":"3","key":"8275_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1759720X13477714","volume":"5","author":"DL Diab","year":"2013","unstructured":"Diab DL, Watts NB. Bisphosphonate drug holiday: who, when and how long. Ther Adv Musculoskelet Dis. 2013;5(3):107-111.","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"4","key":"8275_CR19","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893-1907.","journal-title":"Qual Quant."},{"key":"8275_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117.","journal-title":"BMC Med Res Methodol."},{"issue":"5","key":"8275_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/1049732311431898","volume":"22","author":"A Macfarlane","year":"2012","unstructured":"Macfarlane A, O'Reilly-de Brun M. Using a theory-driven conceptual framework in qualitative health research. Qual Health Res. 2012;22(5):607-618.","journal-title":"Qual Health Res."},{"key":"8275_CR22","unstructured":"Glanz K, Rimer BK, Viswanath K. eds., 2015. Health behavior: Theory, research, and practice. John Wiley & Sons."},{"issue":"10","key":"8275_CR23","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1111\/jgs.16136","volume":"67","author":"A Linsky","year":"2019","unstructured":"Linsky A, Gellad WF, Linder JA, et al. Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework. J Am Geriatr Soc. 2019;67(10):2018-2022.","journal-title":"J Am Geriatr Soc."},{"issue":"9","key":"8275_CR24","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/jgs.15985","volume":"67","author":"JD Niznik","year":"2019","unstructured":"Niznik JD, Zhao X, He M, et al. Factors Associated With Deprescribing Acetylcholinesterase Inhibitors in Older Nursing Home Residents With Severe Dementia. J Am Geriatr Soc. 2019;67(9):1871-1879.","journal-title":"J Am Geriatr Soc."},{"issue":"4","key":"8275_CR25","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/jgs.16360","volume":"68","author":"JD Niznik","year":"2020","unstructured":"Niznik JD, Hunnicutt JN, Zhao X, et al. Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes. J Am Geriatr Soc. 2020;68(4):736-745.","journal-title":"J Am Geriatr Soc."},{"key":"8275_CR26","doi-asserted-by":"crossref","unstructured":"Thorpe CT, Sileanu FE, Mor MK, et al. Discontinuation of statins in veterans admitted to nursing homes near the end of life. J Am Geriatr Soc. 2020;68(11):2609-2619.","DOI":"10.1111\/jgs.16727"},{"issue":"12","key":"8275_CR27","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.jamda.2021.07.009","volume":"22","author":"MC Odden","year":"2021","unstructured":"Odden MC, Lee SJ, Steinman MA, et al. Deprescribing Blood Pressure Treatment in Long-Term Care Residents. J Am Med Dir Assoc. 2021;22(12):2540-2546 e2542.","journal-title":"J Am Med Dir Assoc."},{"issue":"5","key":"8275_CR28","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/bcp.13861","volume":"85","author":"C Lundby","year":"2019","unstructured":"Lundby C, Graabaek T, Ryg J, et al. Health care professionals\u2019 attitudes towards deprescribing in older patients with limited life expectancy: A systematic review. Br J Clin Pharmacol. 2019;85(5):868-892.","journal-title":"Br J Clin Pharmacol."},{"key":"8275_CR29","doi-asserted-by":"crossref","unstructured":"Doherty AJ, Boland P, Reed J, et al. Barriers and facilitators to deprescribing in primary care: a systematic review. BJGP Open. 2020;4(3):bjgpopen20X101096. Published 2020 Aug 25.","DOI":"10.3399\/bjgpopen20X101096"},{"issue":"3","key":"8275_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/17512433.2020.1730812","volume":"13","author":"M Sawan","year":"2020","unstructured":"Sawan M, Reeve E, Turner J, et al. A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review. Expert Rev Clin Pharmacol. 2020;13(3):233-245.","journal-title":"Expert Rev Clin Pharmacol."},{"issue":"1","key":"8275_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11657-021-01050-0","volume":"17","author":"CS Colon-Emeric","year":"2022","unstructured":"Colon-Emeric CS, Hecker EJ, McConnell E, et al. Improving shared decision-making for osteoporosis pharmacologic therapy in nursing homes: a qualitative analysis. Arch Osteoporos. 2022;17(1):11.","journal-title":"Arch Osteoporos."},{"issue":"8","key":"8275_CR32","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-011-1823-7","volume":"23","author":"F Douglas","year":"2012","unstructured":"Douglas F, Petrie KJ, Cundy T, et al. Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors. Osteoporos Int. 2012;23(8):2135-2140.","journal-title":"Osteoporos Int."},{"issue":"6","key":"8275_CR33","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s00223-022-00948-2","volume":"110","author":"KAP Ralston","year":"2022","unstructured":"Ralston KAP, Phillips J, Krause A, et al. Communicating Absolute Fracture Risk Reduction and the Acceptance of Treatment for Osteoporosis. Calcif Tissue Int. 2022;110(6):698-702.","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"8275_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s11606-019-05384-x","volume":"35","author":"EO Billington","year":"2020","unstructured":"Billington EO, Feasel AL, Kline GA. At Odds About the Odds: Women\u2019s Choices to Accept Osteoporosis Medications Do Not Closely Agree with Physician-Set Treatment Thresholds. J Gen Intern Med. 2020;35(1):276-282.","journal-title":"J Gen Intern Med."},{"issue":"6","key":"8275_CR35","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1093\/gerona\/glx147","volume":"73","author":"SD Berry","year":"2018","unstructured":"Berry SD, Zullo AR, Lee Y, et al. Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model. J Gerontol A Biol Sci Med Sci. 2018;73(6):763-769.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"9","key":"8275_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-016477","volume":"7","author":"G Ioannidis","year":"2017","unstructured":"Ioannidis G, Jantzi M, Bucek J, et al. Development and validation of the Fracture Risk Scale (FRS) that predicts fracture over a 1-year time period in institutionalised frail older people living in Canada: an electronic record-linked longitudinal cohort study. BMJ Open. 2017;7(9):e016477.","journal-title":"BMJ Open."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08275-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-023-08275-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08275-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:06:09Z","timestamp":1719446769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-023-08275-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,27]]},"references-count":36,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["8275"],"URL":"https:\/\/doi.org\/10.1007\/s11606-023-08275-4","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,27]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Colon-Emeric reports grants fro UCB Pharma, outside the submitted work. Dr. Lund reports other financial\u00a0activities from GlaxoSmithKline, outside the submitted work. All other authors have no relevant conflicts to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Funding sources had no role in the study design, data collection and analysis, manuscript preparation, or the decision to submit the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}